In 2014, the worldwide development of all categories in the applied biotech industry maintained a steady growth trend. The global market of regenerative medicine (including biological materials for tissue engineering) was estimated to reach 20.8 billion USD in 2014, and projected to reaching 56.9 billion USD in 2019. The Compound Annual Growth Rate (CAGR) in 2014-2019 is 22.3%. Among the global market in 2014, the market of North America was 9 billion USD, and European market was 8.3 billion USD.
I. Scope of the Industry
II. Overview of the Industry in 2014
III. Analysis of Taiwan's Applied Biotechnology Industry
IV. Outlooks of the Industry
Figure 1 Taiwan's biotech industry sectors and products/services
Figure 2 Output for the applied biotech industry of Taiwan in 2009~2013
Figure 3 Years of overseas layout for Taiwan's applied biotech companies in 2014
Figure 4 Forecasting of Taiwan's applied biotech sub-sectors for future growth
Table 1 SWOT analysis of Taiwan's regenerative medicine industry
Table 2 SWOT analysis of Taiwan's food biotech industry
Table 3 SWOT analysis of Taiwan's bio-based specialty chemicals industry
Table 4 SWOT analysis of Taiwan's agricultural biotech industry
Table 5 SWOT analysis of Taiwan's biotech/pharmaceutical service industry